Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms.

Vasdev S, Gill V, Singal PK.

Vasc Health Risk Manag. 2006;2(3):263-76. Review.

2.

Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications.

Vasdev S, Gill V, Singal P.

Cell Biochem Biophys. 2007;49(1):48-63. Review.

PMID:
17873339
3.

Oxidative stress, metabolism of ethanol and alcohol-related diseases.

Zima T, Fialová L, Mestek O, Janebová M, Crkovská J, Malbohan I, Stípek S, Mikulíková L, Popov P.

J Biomed Sci. 2001 Jan-Feb;8(1):59-70.

PMID:
11173977
4.

Low ethanol intake prevents salt-induced hypertension in WKY rats.

Vasdev S, Gill V, Parai S, Gadag V.

Mol Cell Biochem. 2006 Jul;287(1-2):53-60. Epub 2006 May 10.

PMID:
16685463
5.

Exercise, vascular wall and cardiovascular diseases: an update (Part 1).

Leung FP, Yung LM, Laher I, Yao X, Chen ZY, Huang Y.

Sports Med. 2008;38(12):1009-24. doi: 10.2165/00007256-200838120-00005. Review.

PMID:
19026018
6.

Role of oxidative stress in development of cardiovascular complications in diabetes mellitus.

Haidara MA, Yassin HZ, Rateb M, Ammar H, Zorkani MA.

Curr Vasc Pharmacol. 2006 Jul;4(3):215-27. Review.

PMID:
16842139
7.

Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease.

Cleland SJ, Petrie JR, Ueda S, Elliott HL, Connell JM.

Clin Exp Pharmacol Physiol. 1998 Mar-Apr;25(3-4):175-84. Review.

PMID:
9590566
8.
9.

Role of mercury toxicity in hypertension, cardiovascular disease, and stroke.

Houston MC.

J Clin Hypertens (Greenwich). 2011 Aug;13(8):621-7. doi: 10.1111/j.1751-7176.2011.00489.x. Epub 2011 Jul 11. Review.

10.

Endothelial dysfunction in normal and abnormal glucose metabolism.

Esper RJ, Vilariño JO, Machado RA, Paragano A.

Adv Cardiol. 2008;45:17-43. doi: 10.1159/0000115120. Review.

PMID:
18230954
11.

Physio-pathological effects of alcohol on the cardiovascular system: its role in hypertension and cardiovascular disease.

Kawano Y.

Hypertens Res. 2010 Mar;33(3):181-91. doi: 10.1038/hr.2009.226. Epub 2010 Jan 15. Review.

PMID:
20075936
12.

Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.

Holvoet P.

Verh K Acad Geneeskd Belg. 2008;70(3):193-219. Review.

PMID:
18669160
13.

Oxidative stress, AGE, and atherosclerosis.

Schleicher E, Friess U.

Kidney Int Suppl. 2007 Aug;(106):S17-26. Review.

PMID:
17653206
14.

Oxidative stress and non-enzymatic glycation in IgA nephropathy.

Vas T, Wagner Z, Jenei V, Varga Z, Kovács T, Wittmann I, Schinzel R, Balla G, Balla J, Heidland A, Nagy J.

Clin Nephrol. 2005 Nov;64(5):343-51.

PMID:
16312261
15.

Inhibition of advanced glycation endproduct formation by acetaldehyde: role in the cardioprotective effect of ethanol.

Al-Abed Y, Mitsuhashi T, Li H, Lawson JA, FitzGerald GA, Founds H, Donnelly T, Cerami A, Ulrich P, Bucala R.

Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2385-90.

16.

[Oxidative stress and protein glycation in diabetes mellitus].

Gillery P.

Ann Biol Clin (Paris). 2006 Jul-Aug;64(4):309-14. Review. French.

17.

Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.

Montezano AC, Touyz RM.

Can J Cardiol. 2012 May;28(3):288-95. doi: 10.1016/j.cjca.2012.01.017. Epub 2012 Mar 23. Review.

PMID:
22445098
18.

Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.

Cersosimo E, DeFronzo RA.

Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):423-36. Review.

PMID:
16506274
19.

Role of the immune system in hypertension: modulation by dietary antioxidants.

Vasdev S, Stuckless J, Richardson V.

Int J Angiol. 2011 Dec;20(4):189-212. doi: 10.1055/s-0031-1288941.

20.

Supplemental Content

Support Center